{"schema_version":"secwatch.filing_event.v1","accession":"0001528287-24-000015","form_type":"8-K","ticker":"NPCE","cik":"0001528287","company_name":"NeuroPace Inc","filed_at":"2024-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.394920+00:00","generated_at":"2026-05-31T09:41:13.194733+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"NeuroPace Q2 revenue $19.3M (+17% YoY); raises FY2024 guidance to $76-78M","bullets":["Revenue $19.3M (17% YoY) vs $16.5M; net loss $7.5M vs $9.1M prior year.","Gross margin expanded to 73.4% from 72.5%; operating loss narrowed to $6.2M.","Cash burn improved to $4.0M; cash & investments $55.5M; long-term debt $59.0M.","FY2024 revenue guidance raised to $76-78M (16-19% growth); gross margin 72-74%.","Operating expenses $20.4M; R&D $6.1M, SG&A $14.3M; cash burn reduction noted."],"urls":{"canonical":"https://secwatch.observer/filing/0001528287-24-000015","json":"https://secwatch.observer/filing/0001528287-24-000015.json","markdown":"https://secwatch.observer/filing/0001528287-24-000015.md","text":"https://secwatch.observer/filing/0001528287-24-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1528287/000152828724000015/0001528287-24-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1528287/000152828724000015/npce-20240813.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:41:13.194733+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}